Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES CohortSCIENTIFIC REPORTSIF3.92024-10-300PRE
Introduction to the Theme Pharmacological Individuality: New Insights and Strategies for Personalized and Precise Drug TreatmentANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF13.12024-01-230OA
Introduction to the Theme Development of New Drugs: Moving from the Bench to Bedside and Improved Patient CareANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF13.12023-01-202OA
Supporting the Art: Medication Adherence Patterns in Persons Prescribed Ingestible Sensor-enabled Oral Pre-Exposure Prophylaxis to Prevent Human Immunodeficiency Virus (HIV) InfectionCLINICAL INFECTIOUS DISEASESIF7.32022-05-233OA
Introduction to the Theme New Insights, Strategies, and Therapeutics for Common DiseasesANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF13.12022-01-060OA
Introduction to the Theme Old and New Toxicology: Interfaces with PharmacologyANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021IF02021-01-061OA
Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID-19 Therapeutic DevelopmentCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52020-11-2118OAAI
Scientific considerations for global drug developmentSCIENCE TRANSLATIONAL MEDICINEIF14.62020-07-298OAAI
Introduction to the Theme Ion Channels and.Neuropharmacology: From the Past to the FutureANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02020-01-069OAAI
The World Health Organization Prequalification Program and Clinical Pharmacology in 2030CLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52019-11-2612OAAI
Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSDNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATIONIF7.52019-09-0131OAAI
Neuromyelitis optica spectrum disorder Patient experience and quality of lifeNEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATIONIF7.52019-07-0197OAAI
Introduction to the Theme New Therapeutic TargetsANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02019-01-060OA
A Systematic Evaluation of Effect of Adherence Patterns on the Sample Size and Power of a Clinical StudyCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32018-10-2812OAAI
Introduction to the Theme New Approaches for Studying Drug and Toxicant Action: Applications to Drug Discovery and DevelopmentANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02018-01-062OAAI
Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co-encapsulationCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52017-09-1923OAAI
Poor medication adherence in clinical trials: consequences and solutions COMMENTNATURE REVIEWS DRUG DISCOVERYIF101.82017-02-0360PREAI
Introduction to the Theme New Methods and Novel Therapeutic Approaches in Pharmacology and ToxicologyANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02017-01-064OAAI
Introduction to the Theme Cancer PharmacologyANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02016-01-062PRE
Introduction to the Theme Precision Medicine and Prediction in PharmacologyANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGYIF02015-01-0612OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向